Abstract
The relationship between SAF and FEV(1), D (LCO) and X (5), independent of COPD or diabetes. Will individuals with raised SAF and subclinical lung function alterations develop disease? What mechanisms underlie parenchymal alterations indicated by SAF? https://bit.ly/2YTtdkL.